A world-first clinical trial has been launched in the UK for a fridge-free vaccine, which could greatly increase access to jabs.The Stablepharma tetanus-diphtheria vaccine (SPVX02) is completely stable at room temperature and the firm behind it says up to 60 other vaccines may benefit from the advanced technology.The first-in-human trial of the vaccine is taking place at the National Institute for Health and Care Research (NIHR) Southampton clinical research facility at University Hospital Southampton.This could be a real game changer and lifesaver globally – as it unlocks new ways for poorer nations to deliver vaccines to their patients, where they’re often needed the most.
Trump admin takes 100-day victory lap on reforming key agency amid fierce pushback from Dems | Fox News
FIRST ON FOX: As President Trump marks his first 100 days in office on Tuesday, the administration is touting all of their fulfilled campaign promises when it comes to Social Security, an issue where he has been much maligned by Democrats and some in the media. “I am proud of […]
